Inogen (INGN) EPS (Weighted Average and Diluted) (2013 - 2026)
Inogen (INGN) reported EPS (Weighted Average and Diluted) of -$0.3 for Q1 2026, down 20.0% year-over-year from -$0.37 in Q1 2025, and down 11.11% quarter-over-quarter from -$0.27 in Q4 2025.
Inogen (INGN) EPS (Weighted Average and Diluted) (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.3 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.3, down 20.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.92 (up 20.0% YoY), and the FY2025 annual result was -$0.86, up 43.42% from the prior year.
- EPS (Weighted Average and Diluted) fell to -$0.3 in Q1 2026 per INGN's latest filing, from -$0.27 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at -$0.15 in Q2 2022 and troughed at -$2.48 in Q4 2022.
- A 5-year average of -$0.63 and a median of -$0.41 in 2024 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2022 and 2024: EPS (Weighted Average and Diluted) tumbled 1966.67% in 2022, then surged 87.31% in 2024.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$2.48 in 2022, then surged by 54.03% to -$1.14 in 2023, then surged by 64.04% to -$0.41 in 2024, then soared by 34.15% to -$0.27 in 2025, then fell by 11.11% to -$0.3 in 2026.
- Business Quant data shows INGN's EPS (Weighted Average and Diluted) at -$0.3 in Q1 2026, -$0.27 in Q4 2025, and -$0.2 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.24 |
| 10 | Inogen | 176.23 Mn | 81.82 Mn | 37.86 Mn | -0.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.30 |
| Dec 31, 2025 | -0.27 |
| Sep 30, 2025 | -0.20 |
| Jun 30, 2025 | -0.15 |
| Mar 31, 2025 | -0.25 |
| Dec 31, 2024 | -0.41 |
| Sep 30, 2024 | -0.25 |
| Jun 30, 2024 | -0.24 |
| Mar 31, 2024 | -0.62 |
| Dec 31, 2023 | -1.14 |
| Sep 30, 2023 | -1.97 |
| Jun 30, 2023 | -0.42 |
| Mar 31, 2023 | -0.88 |
| Dec 31, 2022 | -2.48 |
| Sep 30, 2022 | -0.42 |
| Jun 30, 2022 | -0.15 |
| Mar 31, 2022 | -0.62 |
| Dec 31, 2021 | -1.01 |
| Sep 30, 2021 | 0.53 |
| Jun 30, 2021 | 0.22 |